Skip to main content

Table 4 Comparison of patient outcomes with combined use of malignant (positive) cytology and mutational profiling

From: The added value of using mutational profiling in addition to cytology in diagnosing aggressive pancreaticobiliary disease: review of clinical cases at a single center

Combined diagnosis

Patient outcome (n = 30)

(Cytology & mutational profiling)

Non-aggressive disease

Aggressive disease

Negative

9

9

Positive

0

12

Non-diagnostic

0

0